RETRACTED ARTICLE: lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway
Authors:
Open Access
- 2 May 2022
- journal article
- retracted article
- Published by Taylor & Francis in Bioengineered
- Vol. 13 (5) , 13667-13679
Abstract
Myocardial hypertrophy leads to heart failure (HF), and emerging researchers have illustrated that long noncoding RNAs (lncRNAs) modulate myocardial hypertrophy. Here, we explored the role and mechanism of a novel lncRNA, NBR2, in modulating angiotensin II (Ang II)-induced myocardial hypertrophy. First, we examined plasma NBR2 levels in 25 patients with HF and myocardial hypertrophy and ten healthy donors and analyzed the correlation between NBR2 profiles and patients’ clinical indicators. In addition, the overexpression experiment of NBR2 was carried out to probe the influence of NBR2 on myocardial hypertrophy. lncRNA NBR2 was down-regulated in plasma of patients with HF and myocardial hypertrophy (vs. healthy controls), and its level was negatively correlated with cardiac function (represented by left ventricular end-diastolic diameter and left ventricular ejection fraction) and degree of myocardial hypertrophy. Besides, Ang II treatment intensified the hypertrophy of human myocardial cell lines (HCM and AC16) and curbed the NBR2 expression. Overexpressing lncRNA NBR2 alleviated Angiotension II–induced myocardial hypertrophy and declined the profiles of hypertrophic markers. Moreover, up-regulating lncRNA NBR2 weakened Ang II-mediated endoplasmic reticulum (ER) stress and activated the LKB1/AMPK/Sirt1 pathway. Interfering with the LKB1/AMPK/Sirt1 axis abated the lncRNA NBR2-mediated inhibitory effect on myocardial hypertrophy and ER stress. This study confirmed that lncRNA NBR2 dampened myocardial hypertrophy and ER stress by modulating the LKB1/AMPK/Sirt1 pathway. Our study provides the first evidence that lncRNA NBR2 is positively associated with myocardial hypertrophy.Keywords
Funding Information
- the Natural Science Foundation of Guangdong Province (2015A030313163)
This publication has 40 references indexed in Scilit:
- MicroRNA-451 Exacerbates Lipotoxicity in Cardiac Myocytes and High-Fat Diet-Induced Cardiac Hypertrophy in Mice Through Suppression of the LKB1/AMPK PathwayCirculation Research, 2015
- Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial functionFree Radical Biology and Medicine, 2014
- Retinoid X Receptor Agonists Inhibit Hypertension-Induced Myocardial Hypertrophy by Modulating LKB1/AMPK/p70S6K Signaling PathwayAmerican Journal of Hypertension, 2014
- Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodellingClinical Science, 2014
- Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and miceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Cardiac Metabolism in Heart FailureCirculation Research, 2013
- Micro-RNA-195 and -451 Regulate the LKB1/AMPK Signaling Axis by Targeting MO25PLOS ONE, 2012
- Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and DysfunctionJournal of Biological Chemistry, 2009
- AMP‐activated protein kinase: a core signalling pathway in the heartActa Physiologica, 2009
- Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.Circulation, 1991